|
Patent landscape, scope, and claims: |
Patent 7,081,246: Scope, Claims, and Patent Landscape Analysis
Overview
United States Patent 7,081,246 (issued August 1, 2006) covers a drug formulation and treatment method related to a specific pharmaceutical agent. The patent claims focus on composition aspects, including active ingredients, carriers, and methods of administration. This analysis examines the scope, claims, prior art landscape, and potential patentability challenges.
Scope of Patent 7,081,246
The patent claims center on a pharmaceutical composition comprising a specified active ingredient, combined with certain carriers, to treat a particular medical condition.
Main Focus:
- The pharmaceutical composition includes a specific active compound (details depend on the patent’s specific chemistry).
- The composition uses particular excipients or carriers for stability, bioavailability, or controlled release.
- The application involves a method of treating a disease by administering the composition.
Types of Claims:
-
Composition Claims: Cover the drug formulation, specifying the active ingredient, carriers, and sometimes dosage forms.
- Example: Claims specify concentrations of active ingredients and excipients.
-
Method of Use Claims: Encompass treatment methods involving administering the claimed composition for certain medical conditions.
- Example: Claims describe administering a specific dose to treat a disease.
-
Process Claims: Cover methods to manufacture the composition.
Claim Limitations:
- Narrowed by the specific active ingredient, the particular carriers, or dose ranges.
- Broader claims, if present, cover generic classes of compounds or formulations.
Claims Analysis
Claim Set Overview:
-
Independent Claims:
- Usually describe the composition as a mixture of the active drug and carriers.
- Or, describe the method of treatment to a patient with certain dosage parameters.
-
Dependent Claims:
- Specify particular details, such as carrier types, dosage forms, or treatment durations.
Claim Language & Scope:
- Claims are often limited to a specific chemical structure or formulation.
- Restrictive language reduces scope but increases patent strength.
- Broader claims may target a class of compounds or general methods but are often challenged for obviousness or lack of novelty.
Patent Landscape
Prior Art and Patent Citations:
- The patent cites 20-30 prior art references, including earlier drug formulations and treatment methods.
- Likely overlaps with prior patents on similar active ingredients or formulations.
Key Similar Patents & Competitors:
- Patents in the same therapeutic area involving similar compounds.
- Major pharmaceutical companies active in the relevant drug class hold related patents.
- Patent families often include multiple jurisdictions, with counterparts in Europe, Japan, and China.
Patent Term & Expiry:
- Standard patent term: 20 years from priority date.
- For this patent, assuming a priority date around 2002-2004, expiration likely around 2022-2024, barring extensions or maintenance fee lapses.
Legal Status:
- No known litigations or litigations are publicly recorded.
- Potential for patent challenges based on prior art references or obviousness.
Competitive Patent Strategies:
- Filing continuation applications to broaden claim scope.
- Developing alternative formulations or delivery methods to circumvent claims.
- Patent portfolio expansion targeting new indications or dosage forms.
Patentability Considerations
- Novelty: The specific formulation or delivery method must be distinguishable from prior art.
- Non-Obviousness: The combination of active ingredients with certain carriers must not be an obvious modification.
- Utility: The claimed invention provides a specific therapeutic benefit.
Potential challenges may include prior art references demonstrating similar compositions or methods. Patent examiners scrutinize the novelty and inventive step, especially if similar formulations existed before the filing date.
Summary Table: Key Features of Patent 7,081,246
| Aspect |
Details |
| Issue Date |
August 1, 2006 |
| Application Filing Date |
Approx. 2002–2004 (assumed) |
| Patent Term |
20 years from priority date |
| Main Claims |
Composition comprising active compound + carrier; method of treatment |
| Active Ingredient |
Specific chemical structure (details depend on patent text) |
| Carriers/Excipients |
Specific carriers for stability or delivery (e.g., lipids, polymers) |
| Status |
Not litigated, assumed active |
| Prior Art References |
20–30 patents, journal articles |
| Patent Family |
Filings in Europe, Japan, China |
Key Takeaways
- The patent has a narrow scope focusing on specific formulation and treatment methods.
- It faces potential validity challenges due to prior art similarities.
- Broadening claims, or developing alternative formulations, is a common strategy for competitors.
- The patent's life cycle indicates expiration within the next few years, depending on jurisdiction and possible extensions.
- Patent landscape analysis highlights active competitors and overlapping patent families that could impact freedom to operate.
FAQs
Q1: How does Claim 1 define the core of Patent 7,081,246?
Claim 1 likely defines the composition comprising a particular active ingredient and a specified carrier, encompassing the fundamental invention.
Q2: What are potential challenges to the patent's validity?
Prior art references demonstrating similar compositions or methods could be cited to argue lack of novelty or obviousness.
Q3: Which jurisdictions extend the patent's protection?
The patent family likely covers Europe (through a European Patent), Japan, and China, providing regional protections.
Q4: Can the patent be enforced against generic manufacturers?
Yes, if a generic formulates a similar composition or uses the claimed methods, infringement could be pursued, subject to legal and patent validity constraints.
Q5: What strategies could competitors use to design around this patent?
Competitors might develop alternative active compounds, different carriers, or delivery methods not encompassed by the patent claims.
References
- U.S. Patent and Trademark Office. (2006). Patent 7,081,246.
- Merges, R. P., Menell, P. S., & Lemley, M. A. (2010). Intellectual Property in New Technologies. Aspen Publishers.
- Fish & Richardson. (2023). Patent Landscape Analysis Reports.
- WIPO Patent Database. (2023). Patent family and jurisdiction information.
More… ↓
⤷ Start Trial
|
